Top Markets
#1 DogBull DogBull +108.80%
#2 MarsCoin MarsCoin +74.07%
#3 Siacoin Siacoin +56.02%
#4 ADO Protocol ADO Protocol +52.76%
#5 The Bitcoin Bull The Bitcoin Bull +26.51%
#6 Ontology Gas Ontology Gas +22.36%
#7 Useless Coin Useless Coin +16.23%
#8 Apertum Apertum +15.00%
#9 Uniswap Uniswap +13.46%
#10 Arowana Arowana +12.91%
Coin of the day
DogBull DogBull
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Rangering i aksjer #15117
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Aksjekurs
$4.74
Sist synkronisert: 2026-08-31
Markedsverdi
$372.19M
Endring (1 dag)
-2.47%
Endring (1 år)
-1.04%
Land
US
Handel Lexeo Therapeutics, Inc. Common Stock (LXEO)

Kategori

Healthcare
P/B-forhold for Lexeo Therapeutics, Inc. Common Stock (LXEO)
P/B-forhold per 2026 TTM: 0
Ifølge Lexeo Therapeutics, Inc. Common Stock sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Lexeo Therapeutics, Inc. Common Stock fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH